Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |